Clinical Trials and Similar Human Studies
Last updated: 2025 Jul 18
Total hit(s): 23615
S.No.
1
40613498
Hydrophobin-Fused SARS-CoV-2 RBD production in Nicotiana benthamiana L. for COVID-19 serology.
Future Sci OA
2025 Dec
3.25
1
2
40552782
Prevalence and prognosis of sarcopenia in acute COVID-19 and long COVID: a systematic review and meta-analysis.
Ann Med
2025 Dec
3.01
1
3
39720838
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged >/=18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial.
Expert Rev Vaccines
2025 Dec
4.37
1
4
40214201
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector.
Hum Vaccin Immunother
2025 Dec
4.7
1
5
40546248
Impact of Stress Hyperglycemia in a Cohort of Brazilian Patients With COVID-19.
Am J Med Open
2025 Dec
1
6
39865693
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial.
Hum Vaccin Immunother
2025 Dec
4.7
1
7
40381203
Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac(R)) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled study.
Hum Vaccin Immunother
2025 Dec
4.7
1
8
40411306
Antibody-dependent enhancement of SARS-CoV-2, the impact of variants and vaccination.
Hum Vaccin Immunother
2025 Dec
4.7
1
9
40465510
Longitudinal study on SARS-CoV-2 antibody responses in companion animals, Chile.
Vet Q
2025 Dec
8.5
1
10
40195167
Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study.
Expert Rev Vaccines
2025 Dec
4.37
1
11
40625176
A second-generation, self-amplifying COVID-19 Vaccine: World's first approval and distribution in the Japanese market with vaccine hesitancy.
Hum Vaccin Immunother
2025 Dec
4.7
1
12
40032512
Involvement of oxidative stress in post-acute sequelae of COVID-19: clinical implications.
Redox Rep
2025 Dec
1
13
40028815
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.
Hum Vaccin Immunother
2025 Dec
4.7
1
14
40358138
Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals.
Hum Vaccin Immunother
2025 Dec
4.7
1
15
40366666
A four-week study on the toxicity of repeated intramuscular administration of plant-based BA-CoV2-0301 vaccine against SARS-CoV-2 in Sprague-Dawley rats.
J Immunotoxicol
2025 Dec
1
16
40497727
The effect of SARS-CoV-2 and influenza vaccination on endemic coronavirus-related mortality: A retrospective cohort study in Brazil.
Hum Vaccin Immunother
2025 Dec
4.7
1
17
40590376
SARS-CoV-2 RNA-binding protein suppresses extracellular miRNA release.
RNA Biol
2025 Dec
1
18
40376714
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial.
Hum Vaccin Immunother
2025 Dec
4.7
1
19
40135763
Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies.
Ann Med
2025 Dec
3.01
1
20
40134119
Gaps in vaccine clinical trials in Africa: A mixed scoping review and bibliometric analysis before, during, and post- COVID-19 pandemic.
Hum Vaccin Immunother
2025 Dec
4.7
1
21
39635731
Nationwide seroprevalence of SARS-CoV-2 Delta variant and five Omicron sublineages in companion cats and dogs in the USA: insights into their role in COVID-19 epidemiology.
Emerg Microbes Infect
2025 Dec
5.84
1
22
40599251
COVID-19 related symptoms and the second infection status of SARS-CoV-2 in patients with lung cancer: A single-center, six-month longitudinal observational study.
Asia Pac J Oncol Nurs
2025 Dec
1
23
40051347
Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection.
Hum Vaccin Immunother
2025 Dec
4.7
1
24
39887328
Willingness to pay for the effect of SARS-CoV-2 antivirals in preventing COVID-19 transmission to others in the Japanese population.
J Med Econ
2025 Dec
1
25
40580117
Impact of the COVID-19 pandemic on lung cancer screening utilization and outcome: a health examination center retrospective study.
Ann Med
2025 Dec
3.01
1